Cargando…
Pulmonary vascular and cardiac impairment in interstitial lung disease
Pulmonary vascular and cardiac impairment is increasingly appreciated as a major adverse factor in the natural history of interstitial lung disease. This clinically orientated review focuses on the current concepts in the pathogenesis, pathophysiology and implications of the detrimental sequence of...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488566/ https://www.ncbi.nlm.nih.gov/pubmed/28096284 http://dx.doi.org/10.1183/16000617.0053-2016 |
_version_ | 1784792686734082048 |
---|---|
author | Panagiotou, Marios Church, Alistair C. Johnson, Martin K. Peacock, Andrew J. |
author_facet | Panagiotou, Marios Church, Alistair C. Johnson, Martin K. Peacock, Andrew J. |
author_sort | Panagiotou, Marios |
collection | PubMed |
description | Pulmonary vascular and cardiac impairment is increasingly appreciated as a major adverse factor in the natural history of interstitial lung disease. This clinically orientated review focuses on the current concepts in the pathogenesis, pathophysiology and implications of the detrimental sequence of increased pulmonary vascular resistance, pre-capillary pulmonary hypertension and right heart failure in interstitial lung disease, and provides guidance on its management. |
format | Online Article Text |
id | pubmed-9488566 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-94885662022-11-14 Pulmonary vascular and cardiac impairment in interstitial lung disease Panagiotou, Marios Church, Alistair C. Johnson, Martin K. Peacock, Andrew J. Eur Respir Rev Reviews Pulmonary vascular and cardiac impairment is increasingly appreciated as a major adverse factor in the natural history of interstitial lung disease. This clinically orientated review focuses on the current concepts in the pathogenesis, pathophysiology and implications of the detrimental sequence of increased pulmonary vascular resistance, pre-capillary pulmonary hypertension and right heart failure in interstitial lung disease, and provides guidance on its management. European Respiratory Society 2017-01-18 /pmc/articles/PMC9488566/ /pubmed/28096284 http://dx.doi.org/10.1183/16000617.0053-2016 Text en Copyright ©ERS 2017. https://creativecommons.org/licenses/by-nc/4.0/ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
spellingShingle | Reviews Panagiotou, Marios Church, Alistair C. Johnson, Martin K. Peacock, Andrew J. Pulmonary vascular and cardiac impairment in interstitial lung disease |
title | Pulmonary vascular and cardiac impairment in interstitial lung disease |
title_full | Pulmonary vascular and cardiac impairment in interstitial lung disease |
title_fullStr | Pulmonary vascular and cardiac impairment in interstitial lung disease |
title_full_unstemmed | Pulmonary vascular and cardiac impairment in interstitial lung disease |
title_short | Pulmonary vascular and cardiac impairment in interstitial lung disease |
title_sort | pulmonary vascular and cardiac impairment in interstitial lung disease |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488566/ https://www.ncbi.nlm.nih.gov/pubmed/28096284 http://dx.doi.org/10.1183/16000617.0053-2016 |
work_keys_str_mv | AT panagiotoumarios pulmonaryvascularandcardiacimpairmentininterstitiallungdisease AT churchalistairc pulmonaryvascularandcardiacimpairmentininterstitiallungdisease AT johnsonmartink pulmonaryvascularandcardiacimpairmentininterstitiallungdisease AT peacockandrewj pulmonaryvascularandcardiacimpairmentininterstitiallungdisease |